Matteo Carlino
MBBS, PhD
Medical Oncologist and Associate Professor
👥Biography 个人简介
Matteo Carlino contributed to the NeoACTIVATE trial investigating neoadjuvant atezolizumab combined with targeted therapy in resectable high-risk melanoma, demonstrating high pathologic response rates. His Australian cooperative work has advanced biomarker-driven neoadjuvant selection. He has shaped combination neoadjuvant strategies for BRAF-mutant and wild-type disease.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Matteo Carlino 的研究动态
Follow Matteo Carlino's research updates
留下邮箱，当我们发布与 Matteo Carlino（Westmead Hospital and University of Sydney）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment